United States · Financial press · Investor's Business Daily
AstraZeneca Gaps Up To Three-Month High As CEO Calls Out $20 Billion Potential
AstraZeneca stock gapped higher Friday as cancer drugs Enhertu and Tagrisso lent themselves to a solid third-quarter report. The post AstraZeneca Gaps Up To Three-Month High As…
Read the full article on Investor's Business Daily Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)
